Showing results (81-90 of 599) with videos related to
Sort By:
Pageof 60
Best Practice & Research. Clinical Haematology|December 7, 2002
Chronic lymphocytic leukaemia: a model for investigating potential new targets for the therapy of indolent lymphomasFederico Caligaris-Cappio, Alessandro Cignetti, Luisa Granziero, et al.Seminars in Cancer Biology|May 25, 2002
Chronic B cell malignancies and bone marrow microenvironmentPaolo Ghia, Luisa Granziero, Marco Chilosi, et al.Leukemia & Lymphoma|January 11, 2021
Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemiaPaolo Ghia, Monika Dlugosz-Danecka, Lydia Scarfò, et al.British Journal of Haematology|December 6, 2023
Primary central nervous system marginal zone lymphomaElena Flospergher, Fabrizio Marino, Teresa Calimeri, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2006
Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphomaSimona Bossolasco, Kerstin I Falk, Maurilio Ponzoni, et al.The American Journal of Surgical Pathology|November 27, 2008
Nodal inflammatory pseudotumor caused by luetic infectionFabio Facchetti, Paolo Incardona, Silvia Lonardi, et al.Frontiers in Oncology|September 29, 2022
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myelomaMatteo Trudu, Laura Oliva, Ugo Orfanelli, et al.Oncology and Therapy|May 14, 2026
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic LeukemiaPaolo Ghia, Jennifer R Brown, Mazyar Shadman, et al.Blood|July 29, 2009
The microenvironment in mature B-cell malignancies: a target for new treatment strategiesJan A Burger, Paolo Ghia, Andreas Rosenwald, et al.Leukemia & Lymphoma|April 7, 2009
Monoclonal B lymphocytosis in the general populationAntonis Dagklis, Claudia Fazi, Lydia Scarfo, et al.Pageof 60